Keywords
Abstract
Relevance. A new coronavirus infection may provoke acute myocardial damage and other new cardiac complications. Because a number of drugs used in COVID-19 have cardiotoxic effects, continuous monitoring of hemodynamic parameters. Viral infection can destabilize the cardiovascular system, which significantly increases the risk of mortality in associated cardiovascular disease (CVD).
Objective: to identify predictors of cardiovascular complications and mortality in patients with COVID-19 against the background of acute respiratory distress syndrome
Materials and Methods: the patients with COVID-19 were included in the study, the appearance of symptoms, health-related quality of life were evaluated, physical examination and laboratory tests were carried out as well as respiratory function and X-ray examination were done in some patients.
Results of the study. The observation was carried out for 50 patients who were admitted to the covid-stationary of Fergana city. Fergana COVID-19. The mean age was 56,7±4,6 including 47 (78,3%) male, 13 (21,6%) female. The duration of the disease (anamnestic from the onset of clinical symptoms to hospitalization) was on the average 14,6±2,5 days, duration of hospitalization was from 14 to 27 days (25,5±1,2). Of those included in the study, 57 (95%) had a history of cardiovascular disease (IHD, AH, CHF, etc.), 46 (92%) had type 2 diabetes, 26 (52%) were overweight and/or obese, and 2 (4%) had newly diagnosed steroid diabetes.
Conclusions: Infectious disease caused by SARS-CoV-2 virus (COVID-19) often occurs in patients with various cardiovascular risk factors, which may influence the course of the infectious process with the development of acute cardiovascular failure, pulmonary embolism against the background of acute respiratory distress syndrome due to the total lesion of lung tissue in likely additional damage to the heart and vessels, contributing to cardiovascular complications and worsening prognosis in patients with COVID-19.